arrow
É

Émeline Tabouret

Utrecht University
H指数:32
被引数:3,935

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neurocognitive Functioning in Long-term Survivors of Glioblastoma, IDH-wildtype and Astrocytoma, IDH-mutant, CNS WHO grade 4: a report from EORTC 1419 (ETERNITY)

长期生存的IDH野生型胶质母细胞瘤和IDH突变型星形细胞瘤(CNS WHO 4级)患者的神经认知功能:EORTC 1419(ETERNITY)研究报告

2026-08-120
OAAI
[177Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial

[ 177 Lu]Lu-DOTATATE治疗复发性脑膜瘤(LUMEN-1,EORTC-2334-BTG):一项随机II期试验研究方案

2026-01-014
PRE
From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials

从同情用药到高级别证据:放射性药物疗法在复发脑膜瘤中的应用——LUMEN-1和MOMENTUM-1试验

2026-01-010
PRE
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial

联合及辅助替莫唑胺治疗1p/19q非共缺失型间变性胶质瘤(CATNON;EORTC研究26053-22054):一项随机、开放标签、III期试验的最终与探索性分析

2025-12-220
PRE
[177Lu]Lu-DOTATATE for recurrent meningioma (LUMEN-1, EORTC-2334-BTG): study protocol for a randomized phase II trial

[177Lu]Lu-DOTATATE治疗复发性脑膜瘤(LUMEN-1,EORTC-2334-BTG):一项随机Ⅱ期试验的研究方案

2025-11-010
OAAI
CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE

IDH突变型高级别胶质瘤中的条件生存分析:临床实践中的有用工具

2025-11-010
OAAI
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas

活检仅且不可切除的IDH野生型胶质母细胞瘤患者的自主生存期

2025-10-160
PRE
PROGNOSIS IMPACT OF PROCARBAZINE AND/OR VINCRISTINE DISCONTINUATION IN FIRST-LINE TREATMENT BY PCV AND RADIOTHERAPY IN WHO GRADE 3 IDH-MUTANT DIFFUSE GLIOMAS

PCB和/或VCR在PCV和放疗的一线治疗中停用对WHO 3级IDH突变型弥漫性胶质瘤预后的影响

2025-10-010
OAAI
CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE

IDH突变型高级别胶质瘤中的条件生存分析:临床实践中的有用工具

2025-10-010
OAAI
A PHASE II STUDY OF AN ANTI-TERT VACCINE (UCPVAX) WITH OR WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA

一项针对新诊断胶质母细胞瘤的II期研究,研究一种抗TERT疫苗(UCPVAX),单独使用或与替莫唑胺联用。

2025-10-010
OAAI
DECIPHERING GLIOBLASTOMA METABOLIC SIGNATURE: MOLECULAR PROFILING AND NADH-FLIM IMAGING

解析胶质母细胞瘤代谢特征:分子谱分析与NADH-FLIM成像

2025-10-010
OAAI
Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935

更正:Tabouret等人,TP5,一种抑制异常和过度活跃的CDK5/p25的肽抑制剂:一种对抗胶质母细胞瘤的新型治疗策略。Cancers 2020, 12, 1935

2025-09-270
OAAI
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation

健康相关生活质量及认知功能在寡形胶质细胞瘤幸存者中的表现:一项国际横断面调查

2025-08-011
OAAI
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection

欧洲神经肿瘤学协会脑膜瘤靶向治疗分子检测指南

2024-11-230
OAAI